跳转至内容
Merck
CN

B4387

Sigma-Aldrich

5-溴-3-吲哚基β-D-吡喃半乳糖苷

≥98%, powder

别名:

卤代腺苷基-beta-D-半乳糖苷

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C14H16BrNO6
CAS号:
分子量:
374.18
Beilstein:
1550140
MDL编号:
UNSPSC代码:
12352204
PubChem化学物质编号:
NACRES:
NA.83

product name

5-溴-3-吲哚基β-D-吡喃半乳糖苷, ≥98%

质量水平

检测方案

≥98%

形式

powder

溶解性

DMF: 50 mg/mL, clear, colorless

储存温度

−20°C

SMILES字符串

OC[C@H]1O[C@@H](Oc2c[nH]c3ccc(Br)cc23)[C@H](O)[C@@H](O)[C@H]1O

InChI

1S/C14H16BrNO6/c15-6-1-2-8-7(3-6)9(4-16-8)21-14-13(20)12(19)11(18)10(5-17)22-14/h1-4,10-14,16-20H,5H2/t10-,11+,12+,13-,14-/m1/s1

InChI key

LINMATFDVHBYOS-MBJXGIAVSA-N

正在寻找类似产品? 访问 产品对比指南

应用

适用于鉴定lac+细菌菌落的显色底物。5-溴-4-氯-3-吲哚基 β 的替代物-D-吡喃半乳糖苷 (X-Gal),可产生较深的蓝色。

相关产品

产品编号
说明
价格

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

监管及禁止进口产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

H Kodaka et al.
Journal of clinical microbiology, 33(1), 199-201 (1995-01-01)
A new medium containing 5-bromo-4-chloro-3-indolyl-beta-D-glucuronide cyclohexylammonium salt (Glu agar) for Escherichia coli and a new medium containing 5-bromo-3-indolyl-beta-D-galactoside (Gal agar) for beta-galactosidase-positive members of the family Enterobacteriaceae were compared with MacConkey agar in a diagnostic trial with 3,562 urine specimens.
A N Markarian et al.
Bioorganicheskaia khimiia, 13(2), 263-265 (1987-02-01)
A simple and convenient technique has been developed for detection of beta-galactosidase from E. coli on nitrocellulose sheets using a mixture of 5-bromoindol-3-yl-beta-D-galactopyranoside and nitro blue tetrazolium, which enables rapid detection of fmole (10(-15) mole) quantities of the enzyme at
Tushar Gupta et al.
Journal of virology, 89(9), 5124-5133 (2015-02-27)
The E2F family of transcription factors, broadly divided into activator and repressor E2Fs, regulates cell cycle genes. Current models indicate that activator E2Fs are necessary for cell cycle progression and tumorigenesis and are also required to mediate transformation induced by
Hongjun Chen et al.
Journal of virology, 88(17), 10013-10025 (2014-06-20)
Vaccination is the first line of defense against influenza virus infection, yet influenza vaccine production methods are slow, antiquated, and expensive as a means to effectively reduce the virus burden during epidemic or pandemic periods. There is a great need

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门